Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Nurix Therapeutics Q2 EPS $(1.01) Down From $(0.60) YoY

Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(1.01) per share. This is a 68.33 percent decrease over losses of $(0.60) per share from the same period last year.
byBill Haddad
July 7, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(1.01) per share. This is a 68.33 percent decrease over losses of $(0.60) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts